Cargando…
Pretreatment AKR1B10 expression predicts the risk of hepatocellular carcinoma development after hepatitis C virus eradication
AIM: To clarify the association between aldo-keto reductase family 1 member B10 (AKR1B10) expression and hepatocarcinogenesis after hepatitis C virus eradication. METHODS: In this study, we enrolled 303 chronic hepatitis C patients who had achieved sustained virological response (SVR) through interf...
Autores principales: | Murata, Ayato, Genda, Takuya, Ichida, Takafumi, Amano, Nozomi, Sato, Sho, Tsuzura, Hironori, Sato, Shunsuke, Narita, Yutaka, Kanemitsu, Yoshio, Shimada, Yuji, Hirano, Katsuharu, Iijima, Katsuyori, Wada, Ryo, Nagahara, Akihito, Watanabe, Sumio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5011670/ https://www.ncbi.nlm.nih.gov/pubmed/27672277 http://dx.doi.org/10.3748/wjg.v22.i33.7569 |
Ejemplares similares
-
Prediction of Hepatocellular Carcinoma Development after Hepatitis C Virus Eradication Using Serum Wisteria floribunda Agglutinin-Positive Mac-2-Binding Protein
por: Sato, Shunsuke, et al.
Publicado: (2016) -
Up-regulated aldo-keto reductase family 1 member B10 in chronic hepatitis C: association with serum alpha-fetoprotein and hepatocellular carcinoma
por: Sato, Shunsuke, et al.
Publicado: (2012) -
Expression of Aldo-Keto Reductase Family 1 Member B10 in the Early Stages of Human Hepatocarcinogenesis
por: Tsuzura, Hironori, et al.
Publicado: (2014) -
On-treatment Serum Mac-2 Binding Protein Glycosylation Isomer (M2BPGi) Level and Risk of Hepatocellular Carcinoma Development in Patients with Chronic Hepatitis B during Nucleot(s)ide Analogue Therapy
por: Murata, Ayato, et al.
Publicado: (2020) -
Eosinophilic Gastroenteritis in an Ulcerative Colitis Patient During Treatment with Tumor Necrosis Factor-alpha Antagonist
por: Hayashida, Sho, et al.
Publicado: (2020)